Best health care companies in Bedford, MA

The Center provides an array of innovative services for persons with mental health conditions, substance use conditions and/or developmental disabilities.

Anika Therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. Anika is committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. With over 20 million procedures performed over the past twenty years utilizing our proprietary technology, Anika is helping individuals all over the world return to life naturally. Anika Therapeutics are innovators and creators. Anika values strong discipline and exceptional focus from their personnel and they employ lean principles and agile processes in managing their business. This foundation of guiding values, combined with our entrepreneurial spirit, gives Anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. Anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care and skin rejuvenation. Anika's proprietary technology is based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body vital for proper joint health and tissue function. At Anika, they believe that an individual's feelings about their age are driven by perceptions about the state of their body. Therefore, Anika's products endeavor to help people feel younger and remain active by delivering safe, effective and minimally invasive treatments to manage pain, restore joint health and tissue function and support wound healing. Anika is incorporated as a spin-off of MedChem Products, Inc.

Carleton-Willard offers the very best in retirement living, including independent living apartments, assistance in living, skilled nursing and rehabilitation services, and support for those with Alzheimer's disease and other dementias.

LogixHealth is nationally recognized for its coding and compliance expertise, and as such provides audits and consultations to groups and companies that are undergoing government and private payer audits.LogixHealth provides office-based and hospital-based physician practices unsurpassed coding, billing, compliance and auditing services nationwide, offering complete full service, end-to-end coding and billing for millions of visits annually.LogixHealth provides comprehensive revenue cycle solutions for both the facility technical component and for the physician professional component.

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health. The Company has built a human-centric proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.

Our application-specific cell purification tools at Cytonome minimize required space, cost and training while maximizing effectiveness and efficiency.

Boston MedFlight provides emergency and inter-facility air and ground critical care transport in Boston and New England. Mobile medical response by helicopter, plane and ground vehicles.

Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology's proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases and a robust intellectual property portfolio with issued composition of matter patents in the United States for its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.